Price To Earnings Ratio 37.79 | Sector PE 69.55 |
PB Ratio 7.76 | Sector PB 8.96 |
EPS 60.18 | Dividend Yield 0.38 |
Today's Volume 79.050 K | 5 Day Avg. Volume 150.443 K |
PEG Ratio 1.77 | Market Cap. ₹ 18,600.00 Cr. |
Caplin Point Laboratories Limited is an Indian pharmaceutical company. The company manufactures, develops and distributes various generic and branded products and exports to foreign markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectable preparations in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injections in ampoules and vials, eye drops, premix bags, topical medications and sachets (liquids and powders). The company also produces various creams, lotions, gels and creams. Its main research and development facilities are located in Tamil Nadu, India. Its main factory is located in Pondicherry, India. It is present in Latin America (LATAM), South Africa and French-speaking Africa, as well as the Americas and the European region. The company's subsidiaries are Caplin Point Far East Limited and Caplin Steriles Limited.